Welcome to Méridian Strategic Advisors

---

Méridian connects medical technology companies with institutional investors. We work with 3 to 5 companies at a time, breakthrough medical devices, therapeutics, and rehabilitation technologies that have proven their science and need capital to commercialize.

We raise capital for late-stage healthcare companies.

These are startups where the technology works, the team is strong, and patents are secured. They need funding for the final push: clinical trials, regulatory approval, and commercial launch.

On the investor side, we connect family offices and venture capital firms with pre-vetted healthcare opportunities.

- Management integrity

- IP ownership

- Financial viability

- Regulatory pathway

- Ethical standards

If they don't meet these standards, we don't work with them.

Companies pay a monthly retainer (credited at closing).

Success fee: 2.5% cash and 2.5% equity.

Taking equity isn't standard in this business, but it proves we're committed long-term.

For investors, this eliminates months of sorting through unqualified deals. You only see companies that have been rigorously screened and positioned for institutional capital.